Sarcomas with KAT6B/A::KANSL1 fusion were first described in one retroperitoneal and one uterine tumor originally diagnosed as leiomyoma, followed shortly after by a tumor initially diagnosed as uterine leiomyosarcoma [12–14]. This evidence concerns the gene KAT6B and leiomyoma.